Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Advate 1000 IU/2 ml powder and solvent for solution for injection EU/1/03/271/009 |
Recombinant coagulation fviii (octocog alfa) | Takeda Manufacturing Austria AG | — |
| Advate 1000 IU/5 ml powder and solvent for solution for injection EU/1/03/271/003 |
Recombinant coagulation fviii (octocog alfa) | Takeda Manufacturing Austria AG | — |
| Advate 1500 IU/5 ml powder and solvent for solution for injection EU/1/03/271/004 |
Recombinant coagulation fviii (octocog alfa) | Takeda Manufacturing Austria AG | — |
| Advate 2000 IU/5 ml powder and solvent for solution for injection EU/1/03/271/005 |
Recombinant coagulation fviii (octocog alfa) | Takeda Manufacturing Austria AG | — |
| Advate 250 IU/2 ml powder and solvent for solution for injection EU/1/03/271/007 |
Recombinant coagulation fviii (octocog alfa) | Takeda Manufacturing Austria AG | — |
| Advate 250 IU/5 ml powder and solvent for solution for injection EU/1/03/271/001 |
Recombinant coagulation fviii (octocog alfa) | Takeda Manufacturing Austria AG | — |
| Advate 3000 IU/5 ml powder and solvent for solution for injection EU/1/03/271/006 |
Recombinant coagulation fviii (octocog alfa) | Takeda Manufacturing Austria AG | — |
| Advate 500 IU/2 ml powder and solvent for solution for injection EU/1/03/271/008 |
Recombinant coagulation fviii (octocog alfa) | Takeda Manufacturing Austria AG | — |
| Advate 500 IU/5 ml powder and solvent for solution for injection EU/1/03/271/002 |
Recombinant coagulation fviii (octocog alfa) | Takeda Manufacturing Austria AG | — |
| ADZYNMA 1500 IU powder and solvent for solution for injection EU/1/24/1837/002 |
Apadamtase alfa | Takeda Manufacturing Austria AG | — |
| ADZYNMA 500 IU powder and solvent for solution for injection EU/1/24/1837/001 |
Apadamtase alfa | Takeda Manufacturing Austria AG | — |
| Cinryze 500 IU powder and solvent for solution for injection EU/1/11/688/001 |
C1 inhibitor | Takeda Manufacturing Austria AG | — |
| Deqsiga 100 mg/mL solution for infusion/human normal immunoglobulin (IVIg) EU/1/25/1919/001-002 |
Human Normal Immunoglobulin (IV) | Takeda Manufacturing Austria AG | — |
| Fluarix Tetra suspension for injection in pre-filled syringe Influenza vaccine (split virion, inactivated) PA1077/134/001 |
A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238, A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/6/2021, IVR-227), B/Austria/1359417/2021 - like strain (B/Austria/1359417/2021, BVR-26) [Victoria lineage], B/PHUKET/3073/2013 -LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE) | GlaxoSmithKline (Ireland) Limited | Not marketed |
| Influvac sub-unit, suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated) PA23355/031/001 |
A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238, Influenza virus B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26), Influenza A virus, A/Croatia/10136RV/2023 (H3N2) like strain X-425A, Inactivated | Viatris Healthcare Limited | Marketed |
| Influvac Tetra, suspension for injection in pre-filled syringe (influenza vaccine, surface antigen, inactivated) PA23355/016/001 |
A/Victoria/2570/2019 (H1N1)pdm09 - like strain (A/Victoria/2570/2019, IVR-215), B/PHUKET/3073/2013 -LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE), B/Austria/1359417/2021 - like strain (B/Michigan/01/2021, wild type), Influenza A virus, A/Croatia/10136RV/2023 (H3N2) like strain X-425A, Inactivated | Viatris Healthcare Limited | Not marketed |
| IXCHIQ powder and solvent for solution for injection Chikungunya vaccine (live) EU/1/24/1828/001 |
Chikungunya virus, strain CHIKV LR2006-OPY1, live attenuated | Valneva Austria GmbH | — |
| Ixiaro 6 AU Suspension for injection EU/1/08/501/1-2 |
Inactivated je virus | Intercell Austria AG | — |
| Lactulose 10 g/15 ml Oral Solution Sachets PA0773/004/001 |
Lactulose | Fresenius Kabi Austria GmbH | Not marketed |
| Lactulose Fresenius 670mg/ml oral solution PA0773/003/001 |
Lactulose | Fresenius Kabi Austria GmbH | Marketed |
| Laevolac Plum 10 g/15 ml oral solution PA0773/005/001 |
Lactulose | Fresenius Kabi Austria GmbH | Not marketed |
| Quadrivalent Influenza Vaccine (split virion, inactivated), suspension for injection in pre-filled syringe Quadrivalent influenza vaccine (split virion, inactivated) PA23458/010/001 |
A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238, B/Austria/1359417/2021 - like strain (B/Michigan/01/2021, wild type), B/PHUKET/3073/2013 -LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE), Influenza A virus, A/Croatia/10136RV/2023 (H3N2) like strain X-425A, Inactivated | Sanofi Winthrop Industrie | Not marketed |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.